Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Results from a FAPESP-supported research center pave the way for expanding the use of photodynamic therapy in the fight against skin cancer.

Scientists at St. Jude Children’s Research Hospital implicated the FOXR2 gene in previously unassociated brain tumor types, with implications for diagnosis, prognosis and treatment.  The potentially practice-changing findings were published today in Neuro-Oncology, a journal of the Society for Neuro-Oncology. 

Adapted Argentine tango dance therapy is helping some breast cancer survivors regain natural balance and sensation after experiencing neuropathy, a common side effect of chemotherapy treatment. Expansion of a new clinical study will look further at how this musical movement intervention can “rewire” the brain to improve function after chemotherapy-related nerve changes. 

Imagine tiny LEGO pieces that automatically snap together to form a strong, flat sheet. Then, scientists add special chemical "hooks" to these sheets to attach glowing molecules called fluorophores. University of Missouri researchers have created these tiny, clay-based materials — called fluorescent polyionic nanoclays. They can be customized for many uses, including advancing energy and sensor technology, improving medical treatments and protecting the environment.

The University of Missouri’s transformative initiative to build a new, state-of-the-art research reactor — NextGen MURR — is officially underway with the signing of the first agreement, announced today. Mizzou will partner with a consortium that includes Hyundai Engineering America, the Korea Atomic Energy Research Institute (KAERI), the Hyundai Engineering Company and MPR Associates for the design and licensing of the new reactor.

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

The liver is the body’s control tower for metabolism, powering vital functions like converting nutrients to glucose, storing fat and breaking down toxins. Over a third of the world, however, is thought to be affected by conditions including metabolic dysfunction-associated steatotic liver disease (MASLD), which jeopardize key liver functions as the condition progresses.

Hepatocyte organoids – the miniature, 3D models of the organ – hold immense promise for accelerating drug development and advancing regenerative therapies. In a study published in Nature, Keio University researchers unveiled a method to proliferate these hard-to-grow organoids by a million-fold in just 3-4 weeks while maintaining key liver functions. “These organoids are potentially the closest laboratory representations of the liver and its multifunctionality,” says senior author Professor Toshiro Sato of the Keio University School of Medicine.

Scientists at The Jackson Laboratory have discovered how aging blood stem cells acquire mutations that give them a growth edge, creating fertile ground for the development of clonol hematopoiesis, a condition that dramatically increases the risk of heart disease, blood cancers, and other illnesses. Importantly, they’ve also identified a method to halt this abnormal growth. This breakthrough provides crucial insight into age-related blood disorders and opens the door to new therapeutic strategies targeting the root cause of these conditions.